Colinz Laboratories Ltd DCF Valuation
COLINZLABORATORIESLTD · Healthcare · Current price
Colinz Laboratories Ltd intrinsic-value estimate
Our intrinsic-value model estimates Colinz Laboratories Ltd is worth ₹64 per share, based on 5% ROE fading to 12% over ~3 yrs, on ₹70 book. Rather than a raw DCF — which is highly sensitive to fragile cash-flow forecasts — we use a residual-income (excess-return) model: a company is worth its book value plus the present value of the returns it earns ABOVE its cost of equity. A none economic moat sets how long that edge is assumed to last.
Try your own assumptions
Prefer a classic discounted-cash-flow view? Open the DCF calculator below — it pre-fills Colinz Laboratories Ltd's real free cash flow, net debt and share count so you can model your own growth and discount-rate scenario in seconds.
More on Colinz Laboratories Ltd
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.